Please join hosts Craig Roush, Senior Counsel, and Jon Witt, Partner, as they discuss current U.S. M&A Lower- Mid-Market (US$25 million – $250 million) trends in Q3 of 2023.
Much has been said about the return of M&A in 2023, and while there are deals happening, it is not the boom that many expected. Additionally, in this changing climate, aspects of middle-market M&A that were once uncommon have begun to standardize and vice versa. In this webinar, speakers will break down the current status of the United States M&A Market in Q3.
To learn more and register to attend, please click here.
People
Related Insights
05 November 2024
Health Care Law Today
Cancer Drugs: Clinical Trial Issues for Antibody Drug Conjugates (ADCs)/Antibody Therapeutics
Antibody Drug Conjugates (ADCs) are a class of small molecule drugs and an antibody conjugated together by a chemical linker.
05 November 2024
Health Care Law Today
New HCPCS for Advanced Primary Care Management
The Center for Medicare & Medicaid Services issued the display copy of the final Calendar Year 2025 Physician Fee Schedule on November 1, 2024, which included three new Healthcare Common Procedure Coding System codes for advanced primary care management.
04 November 2024
Foley Ignite
M&A Market Picking Up Steam: A Look at Q3 Activity
There is finally some very good news in terms of M&A activity, with PitchBook reporting that the “M&A recovery is now hitting its stride.”